Latest BioAlps news
![](https://bioalps.org/app/uploads/2018/07/icon-line-bicolor.png)
News
Aspivix among the 15th French American Entrepreneurship Award winners
The French American Entrepreneurship Award (FAEA) has concluded its 15th year by recognizing three exceptional early-stage startups led by French…
News
CEIDOS secures support from Innosuisse
The BioArk-based startup announced that its innovation project has been approved by the Innosuisse Innovation Council, securing significant funding. …
News
HAYA Therapeutics Co-Founders win inaugural Andreas & Thomas Struengmann Award
HAYA Therapeutics, SA, announced that HAYA’s Co-Founders Samir Ounzain and Daniel Blessing have received the inaugural Andreas & Thomas Struengmann…
News
Vanarix raised CHF 4 Million to begin new clinical trials
The Biopôle-based startup recently raised CHF 4 Million from private investors to finance new clinical trials and the implementation of…
News
Dandelion Science and the Wyss Center announce AI partnership
The Wyss Center for Bio and Neuroengineering and Dandelion Science announced a partnership focused on a cutting-edge generative AI neuromodulation…
News
Aspivix and Xemperia both receive support from FIT
The Foundation for Technological Innovation (FIT) announced two new loans to Aspivix and Xemperia. Aspivix has been awarded a Tech…
News
How brain decodes other people’s gaze
A UNIGE team has succeeded in determining the exact moment when the brain detects another person’s gaze direction. …
News
Actival and Neuria receive CHF 40’000 from Venture Kick
Actival and Neuria Digital Therapeutics were selected at Venture Kick’s second financial and entrepreneurial support stage. Actival: 3D…
News
Four Swiss Health Valley biotech companies worth keeping an eye out for in 2024
Labiotech.eu, a leading digital media covering the European Biotech industry, published a list of Swiss biotech companies to put on…
News
Consulto secures CHF 400’000 Innosuisse Innovation Grant
EPFL startup, Consulto, has been awarded a CHF 400’000 grant in collaboration with EPFL, CHUV, the University of Basel, and…
News
The Patient Quality of Life Challenge announced its finalists
Supported by Debiopharm, La-Solution.ch and the Inartis Foundation, the aim of this award is to support a selection of projects…
News
iOnctura announces €80 Million Series B
iOnctura, a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers, announced that it has closed an €80 Million Series B…